An expert discusses the need to tailor treatment duration in bladder cancer, balancing improved outcomes with toxicity and ...

TAR-200 demonstrated high DFS and bladder preservation rates in BCG-unresponsive, high-risk non-muscle-invasive bladder cancer with papillary-only disease. The phase 2b SunRISe-1 study showed over 80% ...

Learn expert-backed tips for lessening the negative effects of metastatic bladder cancer treatment.

Urology is often perceived in the media as a specialty focused on male health — particularly prostate disease and erectile ...